NCT01355172View on ClinicalTrials.gov

Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

AdimFlu-S

0.25mL per injection 2 injections at 4 weeks apart

Trial Locations (1)

404

China Medicine University Hospital, Taichung

Sponsors
All Listed Sponsors
lead

Adimmune Corporation

INDUSTRY